Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912057-00-053426
Filing Date
2000-12-14
Accepted
2000-12-14 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G a2033274zsc13g.txt SC 13G 8610
  Complete submission text file 0000912057-00-053426.txt   10455
Mailing Address SCHWARZWALDALLEE 215 4002 BASEL SWITZERLAND V8
Business Address SCHWARZWALDALLEE 215 4002 BASEL SWITZERLAND 2128302413
NOVARTIS INC (Filed by) CIK: 0001030617 (see all company filings)

 

Mailing Address 240 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 240 E GRAND AVE SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Subject) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-59985 | Film No.: 788781
SIC: 8731 Services-Commercial Physical & Biological Research